Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair shedding is one of the questions our prescribers hear most often from people starting semaglutide. The short answer: semaglutide itself is not believed to directly cause hair loss, but a significant number of people do notice more shedding in the months after starting treatment. The most likely explanation is a well-documented stress response called telogen effluvium, triggered by rapid weight loss rather than the medicine itself. Semaglutide is a prescription-only medicine, and any concerns about hair changes during treatment should be discussed with your prescriber — who can look at the full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people ask whether Wegovy makes you lose hair, the conversation quickly leads to a distinction worth understanding clearly. Hair thinning or shedding reported by people taking semaglutide appears in clinical trial data, but so does it in trials for other weight-loss interventions, including surgery. The STEP 1 trial, published in the New England Journal of Medicine, reported alopecia (hair loss) as an adverse event in a small percentage of participants on semaglutide 2.4mg, slightly more than in the placebo group. Crucially, the placebo group also recorded some hair loss, which points toward the weight-loss process itself being the main driver.
Telogen effluvium is the mechanism most clinicians point to. Every hair follicle cycles through growth, transition and rest phases. A significant physical stressor (rapid calorie reduction, illness, surgery, even a crash diet) can nudge a larger-than-usual proportion of follicles into the resting phase at the same time. Six to twelve weeks later, those hairs shed. The timing often catches people off guard, because by then they feel well and the weight loss feels like a success. The shedding looks alarming in the shower or on a hairbrush, but it reflects what happened months earlier.
This does not mean the experience is trivial. Visible hair thinning affects confidence, and if you want a fuller picture of what the research and clinical experience actually show, our page exploring whether Wegovy can make you lose your hair is worth reading before drawing any conclusions.
The body treats a sharp reduction in calories as a form of stress, regardless of whether that reduction is intentional and medically supervised. GLP-1 medicines like Wegovy reduce appetite substantially (that is how they work) and some people find their intake drops quite quickly in the early weeks. If protein, iron, zinc or biotin intake falls alongside overall calories, the hair follicles are among the first tissues to feel the pinch. Hair growth is energetically expensive and non-essential; the body deprioritises it.
This is one reason nutritional quality during treatment matters as much as calorie quantity. Our prescribers routinely flag protein targets to patients starting semaglutide, a general pointer is that adequate protein intake (a figure a dietitian or your prescriber can personalise) helps preserve lean mass and supports follicle health. Staying hydrated and keeping micronutrient intake up through varied, nutrient-dense food makes a practical difference. If you are also taking iron supplements or suspect a deficiency, a simple blood test with your GP can clarify whether that is contributing.
Shedding driven by telogen effluvium generally resolves within six to nine months as the body adapts. Hair grows back. The phase of active shedding feels permanent when you are in it, but the follicles themselves are typically undamaged.
There is no current evidence that semaglutide causes permanent or irreversible hair loss. The pattern seen in trials and in clinical practice matches telogen effluvium rather than the kind of follicle damage associated with permanent alopecia. The NHS medicines page for semaglutide lists hair loss among the less common side effects but does not classify it as a serious adverse event.
That said, individual experiences vary. Some people notice very little change; others find the shedding genuinely distressing. If hair loss is severe, accompanied by other symptoms, or persists well beyond the six-to-nine-month window, it is worth raising with your prescriber and potentially a dermatologist. Conditions such as androgenetic alopecia or thyroid dysfunction can run concurrently and may need separate attention, they are not caused by semaglutide but could be unmasked or worsened by nutritional stress. You can read more about the shedding timeline specifically on our page about whether Wegovy causes hair loss.
For those considering starting treatment and worried about this, our free consultation is a good place to raise the question before you begin. A prescriber can talk through your personal history, any nutritional concerns, and what to monitor.
The most useful things you can do sit in three areas: nutrition, monitoring and communication with your clinical team. On nutrition, the priority is protein. Many people find their appetite drops so much in the first few weeks that they undereat not just calories but key building blocks. Aiming for a protein source at every meal (eggs, fish, lean meat, legumes, dairy) keeps the follicles better supplied without requiring a rigid plan.
On monitoring, a note in your phone each time you notice significant shedding, including roughly how much and when, gives your prescriber useful context. Hair loss that starts three months into treatment and resolves by month seven tells a very different story from loss that escalates at month nine.
On communication: there is no need to stop treatment over hair shedding without speaking to your prescriber first. A slower titration pace, a dietary review, or bloodwork to check ferritin and thyroid function can all be part of the response. If you are also curious about how semaglutide produces its weight-loss effects more broadly, the page on how Wegovy drives weight loss covers the underlying mechanism in full.
Hair concerns aside, the REMODEL trial and other recent research continue to build the evidence base for semaglutide's benefits, context that helps put the side-effect profile in perspective. A quick check of our FAQs covers many of the day-to-day questions patients bring to their first appointment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.